CAPRI DIX: Open Payments
NPI 1467087015 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 10 payments from 5 companies in 2025. Trend: 2023 $112 · 2024 $455 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $17 |
Products named: CAPLYTA, INGREZZA, COBENFY, UZEDY, ARISTADA.
Industry payments across NY — which companies pay providers there.
